IL17A and myeloid sarcoma: Alterations in these cytokines may be characteristic of SLE (increased Eotaxin/CCL11, G-CSF, GRO/CXCL1, IFNy, IL-7, and IL-17A) or MS (decreased Fractalkine/CX3CL1 and IL-9).